Cogentin and Symmetrel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cogentin (benztropine mesylate) and Symmetrel (amantadine hydrochloride). Common drug interactions include back pain among females and gait abnormal among males.

The phase IV clinical study analyzes what interactions people have when they take Cogentin and Symmetrel. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Cogentin?

Cogentin has active ingredients of benztropine mesylate. It is often used in tardive dyskinesia. eHealthMe is studying from 7,692 Cogentin users. Check the latest studies of Cogentin.

What is Symmetrel?

Symmetrel has active ingredients of amantadine hydrochloride. It is often used in parkinson's disease. eHealthMe is studying from 3,398 Symmetrel users. Check the latest studies of Symmetrel.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

26 people who take Cogentin and Symmetrel together, and have interactions are studied.

Cogentin and Symmetrel drug interactions.

What are the common drug interactions of Cogentin and Symmetrel, by gender? *:

female:

  1. Back pain
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Cervicitis (inflammation of the uterine cervix)
  4. Chest pain
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Cough
  7. Crush injury (compression of extremities or other parts of the body that causes muscle swelling and/or neurological disturbances)
  8. Delusion (a false belief or opinion)
  9. Diarrhoea
  10. Dizziness

male:

  1. Gait abnormal
  2. Ataxia (loss of full control of bodily movements)
  3. Cerebral oedema (swelling of brain)
  4. Confusion
  5. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  6. Hepatic congestion (liver congestion)
  7. Laceration (tearing of soft body tissue)
  8. Muscle hypertrophy (a term for the growth and increase of the size of muscle cells)
  9. Muscle stiffness
  10. Oedema lower limb (fluid collection in tissue of lower leg)

What are the common drug interactions of Cogentin and Symmetrel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Cervicitis (inflammation of the uterine cervix)
  3. Chest pain
  4. Cough
  5. Crush injury (compression of extremities or other parts of the body that causes muscle swelling and/or neurological disturbances)
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Diarrhoea
  8. Dizziness
  9. Hallucination, auditory (perceiving sounds without auditory stimulus)
  10. Hallucination, visual (seeing things that aren't there)

30-39:

  1. Ataxia (loss of full control of bodily movements)
  2. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  3. Drug toxicity
  4. Fall
  5. Gait abnormal
  6. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
  7. Cardiac disorder
  8. Cerebral oedema (swelling of brain)
  9. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  10. Hepatic congestion (liver congestion)

40-49:

  1. Dyspnoea exertional (breathlessness or shortness of breath)
  2. Oedema peripheral (superficial swelling)
  3. Swelling
  4. Adjustment disorder
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Cardiac failure congestive
  7. Cataract (clouding of the lens inside the eye)
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  10. Deafness

50-59:

  1. Type 2 diabetes mellitus
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Hyperglycaemia (high blood sugar)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Vision blurred

60+:

  1. Balance disorder
  2. Gait abnormal
  3. Psychomotor hyperactivity (feelings of extreme restlessness)
  4. Death
  5. Dysarthria (speech disorder)
  6. Eosinophil count decreased
  7. Fatigue (feeling of tiredness)
  8. Haemoglobin decreased
  9. Hypertension (high blood pressure)
  10. Limb discomfort (discomfort in leg)

What are the existing conditions these people have? *

  1. Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 3 people, 11.54%
  2. Irritable Bowel Syndrome: 2 people, 7.69%
  3. High Blood Pressure: 2 people, 7.69%
  4. Depression: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Cogentin and Symmetrel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cogentin and Symmetrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cogentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Symmetrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cogentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Symmetrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on benztropine mesylate and amantadine hydrochloride (the active ingredients of Cogentin and Symmetrel, respectively), and Cogentin and Symmetrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: